Condition: Metabolic Disorders · Hematologic, Immune, or Bone Marrow Disorders · Hemoglobinopathies · Sponsor: Washington University School of Medicine
The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient for engraftment of donor hematopoietic cells. It is also to determine major toxicities from these conditioning regimens, within the first 100 days after transplantation.
This description comes directly from the study's public registry record.
Lissy Keller, CCRP · 3142861168 · kellerl@wustl.edu
Ian Snyder, CCRP · 3142735953 · ian.s@wustl.edu
Always discuss trial participation with your own doctor first.
| Phoenix Children's Hospital | Phoenix, Arizona, United States | Recruiting |
| Children's Hospital of Orange County | Orange, California, United States | Recruiting |
| University of California | San Diego, California, United States | Recruiting |
| Yale School of Medicine | New Haven, Connecticut, United States | Recruiting |
| George Washington University School of Medicine | Washington D.C., District of Columbia, United States | Recruiting |
| Nemours Children's Health | Jacksonville, Florida, United States | Completed |
| University of Miami | Miami, Florida, United States | Recruiting |
| Miami Children's Hospital | Miami, Florida, United States | Completed |
| All Children's Hospital | St. Petersburg, Florida, United States | Completed |
| Children's Memorial Hospital | Chicago, Illinois, United States | Completed |
| Indiana University School of Medicine | Indianapolis, Indiana, United States | Recruiting |
| Children's Hospital of New Orleans | New Orleans, Louisiana, United States | Completed |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00920972